The U.K. National Institute for Health and Care Research awarded £1.5 million (about $1.8 million) for research on an at-home…
Articles by Andrea Lobo, PhD
A 30-year-old woman with cystic fibrosis (CF) and poor lung function gave birth to a healthy child while being…
The Phase 2a clinical trial testing Aridis Pharmaceuticals’ experimental inhaled therapy AR-501 for chronic lung infections in people with…
The antibiotic Xenleta (lefamulin) was well tolerated in a Phase 1 clinical trial in adults with cystic fibrosis…
The Cold Spring Harbor Laboratory (CSHL) has licensed an artificial intelligence platform, developed by Epistemic AI, to accelerate…
Acne might be a side effect of Trikafta therapy in cystic fibrosis (CF) patients, according to a new case…
Use of Kaftrio (elexacaftor, tezacaftor, and ivacaftor), sold in the U.S. as Trikafta, helped a woman with cystic fibrosis (CF)…
In children with cystic fibrosis (CF), certain genetic variants were found to be associated with the rate of absorption…
The Cystic Fibrosis Foundation (CFF) has joined the CEO Action for Diversity and Inclusion, adding its name to…
The U.S. Food and Drug Administration (FDA) approved the expanded use of …